Development of 400 µm Pellets by Extrusion?Spheronization Application with Gelucire 50/02 to Produce a “Sprinkle” Form
Authors:
- 1 January 2004
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 30 (1) , 43-51
Abstract
The aim of this study was to develop monodimensional, spherical particles of 400 microm by extrusion-spheronization. An Alexanderwerk GA65 cylinder extruder with two counter-rotating rollers associated with a Caleva model 15 spheronizer were used. The study was made with an auxiliary substance of fatty consistency and with amphiphilic properties: Gelucire 50/02. The plasticity of the mass can be deduced using a piston extruder. Pellet quality can be determined by particle-size analysis and shape estimation by microscopy. Modifications to the cylinders and the extruder itself are required for feasibility studies of extruded materials of 400 microm. The horizontal plate of the spheronizer had to be adapted to take into account the small size of the extruded materials. For the chosen auxiliary substance, Gelucire 50/02, the formulation of the wet mass to be extruded and the conditions required to obtain this mass were defined. The results show the feasibility of 400 microm pellets with Gelucire 50/02. At least 90% of the pellets have a particle size of between 250 microm and 500 microm and particle shape is acceptable. In this form the dose can be adapted to individual patients. After proving the feasibility of 400 microm spheroids of Gelucire 50/02, the association of a drug with it was considered.Keywords
This publication has 14 references indexed in Scilit:
- The influence of process variables on the preparation and properties of spherical granules by the process of extrusion and spheronisationInternational Journal of Pharmaceutics, 1995
- A Factorial Approach to High Dose Product Development by an Extrusion/Spheronization ProcessDrug Development and Industrial Pharmacy, 1993
- The influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronisationInternational Journal of Pharmaceutics, 1992
- Absorption Characteristics of a New Valproate Formulation: Divalproex Sodium‐Coated Particles in Capsules (Depakote® Sprinkle)The Journal of Clinical Pharmacology, 1990
- Theophylline pharmacokinetics in children, comparing sustained release spheres (Theo-Dur sprinkle) with elixirEuropean Journal of Pediatrics, 1988
- The application of capillary rheometry to the extrusion of wet powder massesInternational Journal of Pharmaceutics, 1987
- Influence of solvent on the availability of testosterone propionate from oily, intramuscular injections in the ratJournal of Pharmacy and Pharmacology, 1987
- The characterization of wet powder masses suitable for extrusion/spheronizationJournal of Pharmacy and Pharmacology, 1985
- Use of Factorial Design to Evaluate Granulations Prepared by SpheronizationJournal of Pharmaceutical Sciences, 1975
- Design and Use of a Laboratory Extruder for Pharmaceutical GranulationsJournal of Pharmaceutical Sciences, 1973